1. Home
  2. NEXT vs BCRX Comparison

NEXT vs BCRX Comparison

Compare NEXT & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NextDecade Corporation

NEXT

NextDecade Corporation

N/A

Current Price

$6.32

Market Cap

2.0B

Sector

Energy

ML Signal

N/A

Logo BioCryst Pharmaceuticals Inc.

BCRX

BioCryst Pharmaceuticals Inc.

N/A

Current Price

$8.10

Market Cap

2.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NEXT
BCRX
Founded
2010
1986
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
2.1B
IPO Year
2014
1995

Fundamental Metrics

Financial Performance
Metric
NEXT
BCRX
Price
$6.32
$8.10
Analyst Decision
Buy
Buy
Analyst Count
5
11
Target Price
$8.70
★ $20.73
AVG Volume (30 Days)
2.1M
★ 4.1M
Earning Date
10-29-2026
11-02-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 381.40
EPS
★ N/A
N/A
Revenue
N/A
★ $25,186,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$4.02
P/E Ratio
★ N/A
N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$4.75
$6.00
52 Week High
$9.24
$11.22

Technical Indicators

Market Signals
Indicator
NEXT
BCRX
Relative Strength Index (RSI) 29.80 40.10
Support Level $6.04 $8.04
Resistance Level $6.47 $9.22
Average True Range (ATR) 0.28 0.28
MACD -0.09 -0.00
Stochastic Oscillator 3.27 33.49

Price Performance

Historical Comparison
NEXT
BCRX

About NEXT NextDecade Corporation

NextDecade Corp is a Houston-based energy company engaged in construction and development activities related to the liquefaction of natural gas, the sale of LNG, and the capture and storage of CO2 emissions. The group is constructing and developing a natural gas liquefaction and export facility located in the Rio Grande Valley near Brownsville, Texas (the Rio Grande LNG Facility). It also engaged in NEXT Carbon Solutions, advancing proprietary processes to lower the cost of utilizing carbon capture and storage (CCS) and help companies reduce their emissions and achieve their clean energy goals.

About BCRX BioCryst Pharmaceuticals Inc.

BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.

Share on Social Networks: